- Home
- ANIX vs NMS Comparison
ANIX vs NMS Comparison
Compare ANIX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- NMS
- Stock Information
- Founded
- ANIX 1982
- NMS 1993
- Country
- ANIX United States
- NMS United States
- Employees
- ANIX N/A
- NMS N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- ANIX Health Care
- NMS Finance
- Exchange
- ANIX Nasdaq
- NMS Nasdaq
- Market Cap
- ANIX 82.7M
- NMS 71.8M
- IPO Year
- ANIX 1987
- NMS N/A
- Fundamental
- Price
- ANIX $3.08
- NMS $12.44
- Analyst Decision
- ANIX Strong Buy
- NMS
- Analyst Count
- ANIX 2
- NMS 0
- Target Price
- ANIX $8.50
- NMS N/A
- AVG Volume (30 Days)
- ANIX 120.2K
- NMS 12.0K
- Earning Date
- ANIX 03-11-2025
- NMS 01-01-0001
- Dividend Yield
- ANIX N/A
- NMS 4.11%
- EPS Growth
- ANIX N/A
- NMS N/A
- EPS
- ANIX N/A
- NMS N/A
- Revenue
- ANIX N/A
- NMS N/A
- Revenue This Year
- ANIX N/A
- NMS N/A
- Revenue Next Year
- ANIX N/A
- NMS N/A
- P/E Ratio
- ANIX N/A
- NMS N/A
- Revenue Growth
- ANIX N/A
- NMS N/A
- 52 Week Low
- ANIX $2.07
- NMS $9.21
- 52 Week High
- ANIX $4.20
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- ANIX 55.10
- NMS 51.03
- Support Level
- ANIX $2.78
- NMS $12.36
- Resistance Level
- ANIX $3.30
- NMS $12.60
- Average True Range (ATR)
- ANIX 0.21
- NMS 0.07
- MACD
- ANIX -0.01
- NMS 0.01
- Stochastic Oscillator
- ANIX 66.15
- NMS 38.46
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.